FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.31 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
... More
